Oppenheimer maintains Cymabay Therapeu at 'outperform' with a price target of $19.00 August 14, 2023 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Oppenheimer maintains P10 Inc at 'outperform' with a price target of $16.00 Back: All Posts Next:Early U.S. Q3 GDP Forecasts Point to Ongoing Economic Growth